1. Chronic liver disease in the human immunodeficiency virus patient.
- Author
-
Acharya C, Dharel N, and Sterling RK
- Subjects
- Anti-HIV Agents adverse effects, Chemical and Drug Induced Liver Injury, Chronic diagnosis, Chemical and Drug Induced Liver Injury, Chronic therapy, Chronic Disease, Coinfection, Disease Progression, HIV Infections drug therapy, Hepatitis B, Chronic complications, Hepatitis B, Chronic diagnosis, Hepatitis B, Chronic drug therapy, Hepatitis C, Chronic diagnosis, Hepatitis C, Chronic drug therapy, Hepatitis C, Chronic pathology, Hepatitis C, Chronic physiopathology, Humans, Infections diagnosis, Infections microbiology, Non-alcoholic Fatty Liver Disease complications, Non-alcoholic Fatty Liver Disease diagnosis, Non-alcoholic Fatty Liver Disease therapy, Reverse Transcriptase Inhibitors adverse effects, Antiretroviral Therapy, Highly Active adverse effects, Chemical and Drug Induced Liver Injury, Chronic etiology, HIV Infections complications, Hepatitis C, Chronic complications
- Abstract
There are an estimated 40 million HIV infected individuals worldwide, with chronic liver disease being the 2nd leading cause of mortality in this population. Elevated liver functions are commonly noted in HIV patients and the etiologies are varied. Viral hepatitis B and C, fatty liver and drug induced liver injury are more common. Treatment options for viral hepatitis C are rapidly evolving and are promising, but treatments are limited for the other conditions and is primarily supportive. Opportunistic infections of the liver are now uncommon. Irrespective of etiology, management requires referral to specialized centers and with due diligence mortality can be reduced., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF